An official website of the United States government

Methods and compositions for protection against thrombolysis associated reperfusion injury

Patent
US-2006263351-A1
Inventor

LO ENG H (US)

WANG XIAOYING (US)

REBECK G WILLIAM (US)

ARAI KEN (JP)

Assignee
GEN HOSPITAL CORP (US)
Country
United States
Dates
  • Priority:
    2002/12/31
Description
This web page summarizes information in PubChem about patent US-2006263351-A1. This includes chemicals mentioned, as reported by PubChem contributors, as well as other content, such as title, abstract, and International Patent Classification (IPC) codes. To read more about how this page was constructed, please visit the PubChem patents help page.

1 Abstract

The invention relates to products and methods for reducing cerebral hemorrhage and edema, which can be negative side-effects of thrombolytic therapies with tissue plasminogen activator (tPA) and/or urokinase plasminogen activator (uPA).

2 Full Text

3 Important Dates

3.1 Priority Date

2002/12/31

3.2 Filing Date

2003/12/22

3.3 Publication Date

2006/11/23

4 Inventor

LO ENG H (US)

WANG XIAOYING (US)

REBECK G WILLIAM (US)

ARAI KEN (JP)

5 Assignee

GEN HOSPITAL CORP (US)

6 Country

United States

7 Linked Chemicals

7.1 PubChem Compounds

7.2 PubChem Substances

8 Linked Proteins

9 Linked Genes

10 Linked Taxonomies

11 Patent Family

12 Classification

12.1 IPC

A61K/ (inventive)

G01N33/86 (inventive)

A01N37/18 (inventive)

A61K39/395 (inventive, first)

A61K38/54 (inventive)

12.2 CPC

G01N2500/00

A61K38/49 (inventive, first)

C12Q1/56 (inventive)

G01N33/92 (inventive)

G01N33/86 (inventive)

13 Citations

14 Cited By

15 Similar Patents

16 Information Sources

  1. Google Patents
    LICENSE
    "Google Patents Research Data" by Google, based on data provided by IFI CLAIMS Patent Services and OntoChem, is licensed under a Creative Commons Attribution 4.0 International License.
    https://creativecommons.org/licenses/by/4.0/legalcode
  2. PubChem
CONTENTS